230 related articles for article (PubMed ID: 22201102)
21. [Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].
Isogai Y
Clin Calcium; 2005 Jan; 15(1):18-24. PubMed ID: 15632468
[TBL] [Abstract][Full Text] [Related]
22. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
Nakamura T
Clin Calcium; 2007 Dec; 17(12):1823-9. PubMed ID: 18057656
[TBL] [Abstract][Full Text] [Related]
23. Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats.
Kuchler U; Spilka T; Baron K; Tangl S; Watzek G; Gruber R
Clin Oral Implants Res; 2011 May; 22(5):518-23. PubMed ID: 21251075
[TBL] [Abstract][Full Text] [Related]
24. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
[TBL] [Abstract][Full Text] [Related]
25. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
[TBL] [Abstract][Full Text] [Related]
26. [Parathyroid hormone for osteroporsis: why and who to treat?].
Ferrari S; Rizzoli R
Rev Med Suisse; 2005 Oct; 1(35):2272-4, 2276-7. PubMed ID: 16268450
[TBL] [Abstract][Full Text] [Related]
27. Teriparatide and orthopedic surgery.
Iolascon G; Gimigliano F; Resmini G
Aging Clin Exp Res; 2007 Aug; 19(4 Suppl):22-5. PubMed ID: 18182888
[TBL] [Abstract][Full Text] [Related]
28. [Bone fracture and the healing mechanisms. The effect of human parathyroid hormone on fracture healing].
Komatsubara S; Mashiba T; Mori S
Clin Calcium; 2009 May; 19(5):660-6. PubMed ID: 19398833
[TBL] [Abstract][Full Text] [Related]
29. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/rhOP-1): histological observations.
Susin C; Qahash M; Polimeni G; Lu PH; Prasad HS; Rohrer MD; Hall J; Wikesjö UM
J Clin Periodontol; 2010 Jun; 37(6):574-81. PubMed ID: 20345394
[TBL] [Abstract][Full Text] [Related]
30. A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution.
Subramanian G; Cohen HV; Quek SY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):744-53. PubMed ID: 21821444
[TBL] [Abstract][Full Text] [Related]
31. [Cytokines in bone diseases. Bone anabolic action of PTH and role of cytokine].
Kaji H; Sugimoto T
Clin Calcium; 2010 Oct; 20(10):1555-61. PubMed ID: 20890039
[TBL] [Abstract][Full Text] [Related]
32. Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
Glover SJ; Eastell R; McCloskey EV; Rogers A; Garnero P; Lowery J; Belleli R; Wright TM; John MR
Bone; 2009 Dec; 45(6):1053-8. PubMed ID: 19679211
[TBL] [Abstract][Full Text] [Related]
33. Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model.
Oki Y; Doi K; Makihara Y; Kobatake R; Kubo T; Tsuga K
J Appl Oral Sci; 2017; 25(5):498-505. PubMed ID: 29069147
[TBL] [Abstract][Full Text] [Related]
34. PTH analogues and osteoporotic fractures.
Verhaar HJ; Lems WF
Expert Opin Biol Ther; 2010 Sep; 10(9):1387-94. PubMed ID: 20629581
[TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis.
Borgström F; Ström O; Marin F; Kutahov A; Ljunggren O
J Med Econ; 2010; 13(3):381-92. PubMed ID: 20604678
[TBL] [Abstract][Full Text] [Related]
36. Treatment of osteoporosis with parathyroid hormone and teriparatide.
Pleiner-Duxneuner J; Zwettler E; Paschalis E; Roschger P; Nell-Duxneuner V; Klaushofer K
Calcif Tissue Int; 2009 Mar; 84(3):159-70. PubMed ID: 19189037
[TBL] [Abstract][Full Text] [Related]
37. [PTH preparations].
Fukumoto S
Nihon Rinsho; 2015 Oct; 73(10):1696-700. PubMed ID: 26529932
[TBL] [Abstract][Full Text] [Related]
38. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
[TBL] [Abstract][Full Text] [Related]
39. Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw: a case report and narrative review.
Thumbigere-Math V; Gopalakrishnan R; Michalowicz BS
Northwest Dent; 2013; 92(1):12-8. PubMed ID: 23516715
[TBL] [Abstract][Full Text] [Related]
40. Teriparatide (rh [1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening.
Oteo-Álvaro Á; Matas JA; Alonso-Farto JC
Orthopedics; 2011 Sep; 34(9):e574-7. PubMed ID: 21902160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
